DC Business DC

Vienna biotech Cel-Sci regains compliance with NYSE American

Washington Business Journal

Jan 15, 2019

Cel-Sci Corp. has regained compliance on the New York Stock Exchange American. The Vienna biotech said Tuesday that it received a notice from NYSE American staff indicating the com…

Read the full story at Washington Business Journal

Topics

#Biotech

Vienna biotech Cel-Sci regains compliance with NYSE American

Topics

More from DC Business

Shilling Canning files for bankruptcy protection amid rent struggles

Steve Case's Revolution teams with Hilton to deliver luxury Costa Rican resort 19 years in the making

Challenge to ACA preventive-care panel draws skepticism from Supreme Court

Can Trump remove Powell as Fed chair before his term ends?

Amazon closing one of its Northern Virginia supermarkets

International travelers give D.C.'s hospitality business only slight boost

Drone firm announces Virginia expansion and college partnership

Mixed-use development in downtown Bethesda looks to add more retail, residences